- Home
- INVA vs FOR Comparison
INVA vs FOR Comparison
Compare INVA & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- FOR
- Stock Information
- Founded
- INVA 1996
- FOR 2005
- Country
- INVA United States
- FOR United States
- Employees
- INVA N/A
- FOR N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- FOR Real Estate
- Sector
- INVA Health Care
- FOR Finance
- Exchange
- INVA Nasdaq
- FOR Nasdaq
- Market Cap
- INVA 1.1B
- FOR 1.3B
- IPO Year
- INVA 2004
- FOR 2007
- Fundamental
- Price
- INVA $18.23
- FOR $25.04
- Analyst Decision
- INVA Buy
- FOR Strong Buy
- Analyst Count
- INVA 5
- FOR 4
- Target Price
- INVA $35.60
- FOR $31.25
- AVG Volume (30 Days)
- INVA 718.0K
- FOR 125.4K
- Earning Date
- INVA 11-05-2025
- FOR 10-28-2025
- Dividend Yield
- INVA N/A
- FOR N/A
- EPS Growth
- INVA N/A
- FOR N/A
- EPS
- INVA 0.53
- FOR 3.29
- Revenue
- INVA $370,229,000.00
- FOR $1,662,400,000.00
- Revenue This Year
- INVA $7.98
- FOR $1.24
- Revenue Next Year
- INVA $11.60
- FOR $8.97
- P/E Ratio
- INVA $34.20
- FOR $7.61
- Revenue Growth
- INVA 12.02
- FOR 10.14
- 52 Week Low
- INVA $16.52
- FOR $18.00
- 52 Week High
- INVA $22.00
- FOR $33.06
- Technical
- Relative Strength Index (RSI)
- INVA 54.24
- FOR 40.72
- Support Level
- INVA $17.45
- FOR $24.69
- Resistance Level
- INVA $18.31
- FOR $26.30
- Average True Range (ATR)
- INVA 0.50
- FOR 1.00
- MACD
- INVA 0.15
- FOR -0.10
- Stochastic Oscillator
- INVA 66.27
- FOR 7.47
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.